New research emphasizes that replacing ultra-processed foods with healthier alternatives may help significantly reduce the ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

Diabetes affects the entire body of those who suffer from it; the Marquette Lions Club wants to make the public aware of ways to prevent its development with a group walk and resource fair. A 2.2-mile ...

UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study ...

Canada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to ...

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

The study, titled ‘Metformin decelerates aging clock in male monkeys’, was published in journal Cell on September 12.